|
Breast Cancer genetic study in African-ancestry populations
|
5R01CA202981-02
|
$2,391,119
|
|
ZHENG, WEI
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
SPORE in Lung Cancer
|
5P50CA058187-22
|
$2,300,000
|
|
BUNN, PAUL
|
UNIVERSITY OF COLORADO DENVER
|
|
Specialized Program Of Research Excellence (SPORE) in Leukemia
|
5P50CA171963-05
|
$2,300,000
|
|
LINK, DANIEL
|
WASHINGTON UNIVERSITY
|
|
Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging
|
5R01CA185687-03
|
$2,177,040
|
|
SMITH-BINDMAN, REBECCA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Investigating the development of AIDs and non-AIDS defining cancers in aged SIV-infected rhesus macaques.
|
5R01CA206404-02
|
$1,555,244
|
|
WONG, SCOTT
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Defining RAS isoform- and mutation-specific roles in oncogenesis
|
5P01CA203657-02
|
$1,542,424
|
|
DER, CHANNING
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Direct and Repeated Clinical Measurement of pO2 for Enhancing Cancer Therapy
|
5P01CA190193-03
|
$1,372,998
|
|
SWARTZ, HAROLD
|
DARTMOUTH COLLEGE
|
|
Molecular Mechanism of Action of Phorbol Ester
|
Z01 BC 005270
|
$1,250,284
|
$62,514
|
Blumberg, Peter
|
CCR (NCI)
|
|
High-throughput sequencing to identify novel melanoma susceptibility genes
|
5R01CA195614-03
|
$1,075,388
|
|
HUFF, CHAD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Comparative Effectiveness of Fecal Immunochemical Tests with Optical Colonoscopy
|
1R01CA215034-01
|
$940,235
|
|
LEVY, BARCEY
|
UNIVERSITY OF IOWA
|
|
Systems Modeling of Tumor Heterogeneity and Therapy Response in Colorectal Cancer
|
1R01CA208179-01A1
|
$853,654
|
|
GINTY, FIONA
|
GENERAL ELECTRIC GLOBAL RESEARCH CTR
|
|
Building protected data sharing networks to advance cancer risk assessment and treatment
|
1U24CA209996-01A1
|
$805,856
|
|
FOSTER, IAN
|
UNIVERSITY OF CHICAGO
|
|
OSU K12 Training Grant for Clinical Faculty Investigators
|
5K12CA133250-09
|
$797,702
|
|
BYRD, JOHN
|
OHIO STATE UNIVERSITY
|
|
Improving Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients
|
5R01CA193673-02
|
$773,975
|
|
SHELBY, REBECCA
|
DUKE UNIVERSITY
|
|
(PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection
|
5R01CA206476-02
|
$772,521
|
|
CHIAO, ELIZABETH
|
BAYLOR COLLEGE OF MEDICINE
|
|
Scalable Clinical Decision Support for Individualized Cancer Risk Management
|
1U24CA204800-01A1
|
$766,250
|
|
DEL FIOL, GUILHERME
|
UNIVERSITY OF UTAH
|
|
Systems approaches to understanding the relationships between genotype, signaling, and therapeutic efficacy
|
1U01CA215798-01
|
$739,468
|
|
LAUFFENBURGER, DOUGLAS
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Oral Microbiome and Lung Cancer Risk
|
5R01CA207466-02
|
$731,073
|
|
CAI, QIUYIN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Integrative approach to heterogeneity in breast cancer metastasis
|
5U01CA199315-02
|
$713,777
|
|
WERB, ZENA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Open Architecture Image-Guided Therapy Software System
|
5R44CA115263-03
|
$713,066
|
$71,307
|
Stefansic, James
|
PATHFINDER THERAPEUTICS
|
|
(PQ8) Genetically faithful murine models for studying disease progression in chronic lymphocytic leukemia
|
1R01CA216273-01
|
$701,924
|
|
WU, CATHERINE
|
DANA-FARBER CANCER INST
|
|
[PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer Prognosis
|
5R01CA185251-04
|
$700,207
|
|
BEEBE, DAVID
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Precision Medicine Approach to Prostate Cancer Active Surveillance
|
5R01CA184712-04
|
$695,027
|
|
MOSQUERA, JUAN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Multiscale Modeling of Bone Environment Responses to Metastatic Prostate Cancer
|
5U01CA202958-02
|
$690,824
|
|
BASANTA GUTIERREZ, DAVID
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
High Throughput Screening to Discover Chemical Inhibitors of Quiescin Sulfhydryl Oxidase 1
|
5R01CA201226-02
|
$678,423
|
|
FAIGEL, DOUGLAS
|
MAYO CLINIC ARIZONA
|
|
Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy
|
5R01CA204924-02
|
$669,635
|
|
BLASBERG, RONALD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Understanding and Targeting Chemotherapy Resistance in Acute Myeloid Leukemia
|
5R01CA198089-03
|
$663,135
|
|
CARROLL, MARTIN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Analysis of Tobacco Industry Documents
|
5R01CA087472-18
|
$655,138
|
|
GLANTZ, STANTON
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Large-Area Plasma Panel Detectors for Particle Beam Radiation Therapy
|
5R44CA183437-03
|
$650,488
|
|
FRIEDMAN, PETER
|
INTEGRATED SENSORS, LLC
|
|
Novel immunological biomarkers ovarian cancer prognosis
|
5R01CA188900-03
|
$646,389
|
|
SEGAL, BRAHM
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Program for Training in Cancer Epidemiology
|
5T32CA009001-42
|
$642,687
|
|
STAMPFER, MEIR
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
Targeting Kinesin Family Member 15 for the Treatment of Cancer
|
1R01CA214545-01
|
$641,589
|
|
GODWIN, ANDREW
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
A scalable platform for target validation in GEMM models of gastrointestinal malignancies.
|
5R01CA195787-03
|
$641,206
|
|
LOWE, SCOTT
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Image-guided ultrasound therapy and drug delivery in pancreatic cancer
|
5R01CA210553-02
|
$636,467
|
|
FERRARA, KATHERINE
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Isozyme-selective ALDH Inhibitors for Sensitizing Ovarian Cancer Stem-like Cells to Chemotherapy
|
1R01CA214567-01
|
$636,181
|
|
LARSEN, SCOTT
|
UNIVERSITY OF MICHIGAN
|
|
Employing the Myc Transcriptional Network to Reveal Oncogenic Pathways
|
5R01CA057138-26
|
$635,460
|
|
EISENMAN, ROBERT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
WASHINGTON UNIVERSITY CO-CLINICAL IMAGING RESEARCH RESOURCE
|
1U24CA209837-01A1
|
$632,875
|
|
SHOGHI, KOORESH
|
WASHINGTON UNIVERSITY
|
|
PLEKHA7 A Novel Target for Mutant KRAS Therapy
|
5R01CA185054-03
|
$624,131
|
|
POWIS, GARTH
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
|
Elimination of Instrumental Bias for Quantitative Diffusion Imaging in Clinical Oncology Trials
|
5R01CA190299-03
|
$615,807
|
|
CHENEVERT, THOMAS
|
UNIVERSITY OF MICHIGAN
|
|
Linking the microbiome and immune-checkpoint in melanoma by RNF5
|
1R01CA216187-01
|
$603,580
|
|
BRADLEY, LINDA
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
|
Surgical Oncology Basic Science and Translational Research Training Program
|
5T32CA009621-29
|
$591,993
|
|
GILLANDERS, WILLIAM
|
WASHINGTON UNIVERSITY
|
|
Lab Research Training in Pediatric Oncology-Hematology
|
5T32CA060441-25
|
$583,961
|
|
SMALL, DONALD
|
JOHNS HOPKINS UNIVERSITY
|
|
Multiplexed imaging of biliary intra-epithelial neoplasia
|
5R01CA200007-03
|
$569,599
|
|
SEIBEL, ERIC
|
UNIVERSITY OF WASHINGTON
|
|
Integrated Tools for Quantitative Whole-Body Tumor Perfusion Imaging
|
5R01CA202695-02
|
$566,413
|
|
HUTCHINS, GARY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
(7) Novel imaging devices for measurement and control of tumor microenvironments
|
1R01CA216248-01
|
$565,675
|
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
ROS-targeted therapy for pancreatic cancer
|
5R01CA188252-03
|
$562,471
|
|
NEAMATI, NOURI
|
UNIVERSITY OF MICHIGAN
|
|
Gut microbiota mediated bile acid alterations in hepatic carcinogenesis
|
5U01CA188387-03
|
$562,180
|
|
JIA, WEI
|
UNIVERSITY OF HAWAII AT MANOA
|
|
MYB family alterations in pediatric gliomas
|
1R01CA215489-01
|
$554,504
|
|
LIGON, KEITH
|
DANA-FARBER CANCER INST
|
|
Preclinical characterization of EMT/CSC-specific small molecule inhibitors for TNBCs
|
1R01CA200970-01A1
|
$550,276
|
|
MANI, SENDURAI
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Training Grant in Molecular Imaging Research
|
5T32CA079443-17
|
$539,842
|
|
WEISSLEDER, RALPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
Total relevant funding to Ear for this search: $225,018
|